BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 26028498)

  • 1. The inducible E3 ubiquitin ligases SIAH1 and SIAH2 perform critical roles in breast and prostate cancers.
    Knauer SK; Mahendrarajah N; Roos WP; Krämer OH
    Cytokine Growth Factor Rev; 2015 Aug; 26(4):405-13. PubMed ID: 26028498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SIAH ubiquitin ligases regulate breast cancer cell migration and invasion independent of the oxygen status.
    Adam MG; Matt S; Christian S; Hess-Stumpp H; Haegebarth A; Hofmann TG; Algire C
    Cell Cycle; 2015; 14(23):3734-47. PubMed ID: 26654769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SIAH ubiquitin ligases target the nonreceptor tyrosine kinase ACK1 for ubiquitinylation and proteasomal degradation.
    Buchwald M; Pietschmann K; Brand P; Günther A; Mahajan NP; Heinzel T; Krämer OH
    Oncogene; 2013 Oct; 32(41):4913-20. PubMed ID: 23208506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phylogenetic analysis of the SINA/SIAH ubiquitin E3 ligase family in Metazoa.
    Pepper IJ; Van Sciver RE; Tang AH
    BMC Evol Biol; 2017 Aug; 17(1):182. PubMed ID: 28784114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a Src tyrosine kinase/SIAH2 E3 ubiquitin ligase pathway that regulates C/EBPδ expression and contributes to transformation of breast tumor cells.
    Sarkar TR; Sharan S; Wang J; Pawar SA; Cantwell CA; Johnson PF; Morrison DK; Wang JM; Sterneck E
    Mol Cell Biol; 2012 Jan; 32(2):320-32. PubMed ID: 22037769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.
    Ma B; Chen Y; Chen L; Cheng H; Mu C; Li J; Gao R; Zhou C; Cao L; Liu J; Zhu Y; Chen Q; Wu S
    Nat Cell Biol; 2015 Jan; 17(1):95-103. PubMed ID: 25438054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of small molecule inhibitors of the ubiquitin ligases Siah1/2 in melanoma and prostate cancer cells.
    Feng Y; Sessions EH; Zhang F; Ban F; Placencio-Hickok V; Ma CT; Zeng FY; Pass I; Terry DB; Cadwell G; Bankston LA; Liddington RC; Chung TDY; Pinkerton AB; Sergienko E; Gleave M; Bhowmick NA; Jackson MR; Cherkasov A; Ronai ZA
    Cancer Lett; 2019 May; 449():145-162. PubMed ID: 30771432
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of SIAH2, an ubiquitin E3 ligase, is associated with resistance to endocrine therapy in breast cancer.
    Jansen MP; Ruigrok-Ritstier K; Dorssers LC; van Staveren IL; Look MP; Meijer-van Gelder ME; Sieuwerts AM; Helleman J; Sleijfer S; Klijn JG; Foekens JA; Berns EM
    Breast Cancer Res Treat; 2009 Jul; 116(2):263-71. PubMed ID: 18629630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The substrate binding domains of human SIAH E3 ubiquitin ligases are now crystal clear.
    Zhang Q; Wang Z; Hou F; Harding R; Huang X; Dong A; Walker JR; Tong Y
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3095-3105. PubMed ID: 27776223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Investigating the molecular basis of Siah1 and Siah2 E3 ubiquitin ligase substrate specificity.
    Gopalsamy A; Hagen T; Swaminathan K
    PLoS One; 2014; 9(9):e106547. PubMed ID: 25202994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DHX15 promotes prostate cancer progression by stimulating Siah2-mediated ubiquitination of androgen receptor.
    Jing Y; Nguyen MM; Wang D; Pascal LE; Guo W; Xu Y; Ai J; Deng FM; Masoodi KZ; Yu X; Zhang J; Nelson JB; Xia S; Wang Z
    Oncogene; 2018 Feb; 37(5):638-650. PubMed ID: 28991234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.
    Qi J; Tripathi M; Mishra R; Sahgal N; Fazli L; Ettinger S; Placzek WJ; Claps G; Chung LW; Bowtell D; Gleave M; Bhowmick N; Ronai ZA
    Cancer Cell; 2013 Mar; 23(3):332-46. PubMed ID: 23518348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of PML-RARα stability by the ubiquitin ligases SIAH1/SIAH2 and TRIAD1.
    Pietschmann K; Buchwald M; Müller S; Knauer SK; Kögl M; Heinzel T; Krämer OH
    Int J Biochem Cell Biol; 2012 Jan; 44(1):132-8. PubMed ID: 22037423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible role of death receptor-mediated apoptosis by the E3 ubiquitin ligases Siah2 and POSH.
    Christian PA; Fiandalo MV; Schwarze SR
    Mol Cancer; 2011 May; 10():57. PubMed ID: 21586138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin ligase Siah2 regulates RevErbα degradation and the mammalian circadian clock.
    DeBruyne JP; Baggs JE; Sato TK; Hogenesch JB
    Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12420-5. PubMed ID: 26392558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoproteins augment hypoxia-induced angiogenesis via regulation of post-translational modulation of hypoxia-inducible factor 1α.
    Tan JT; Prosser HC; Vanags LZ; Monger SA; Ng MK; Bursill CA
    FASEB J; 2014 Jan; 28(1):206-17. PubMed ID: 24022405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EBV latent membrane protein 1 up-regulates hypoxia-inducible factor 1alpha through Siah1-mediated down-regulation of prolyl hydroxylases 1 and 3 in nasopharyngeal epithelial cells.
    Kondo S; Seo SY; Yoshizaki T; Wakisaka N; Furukawa M; Joab I; Jang KL; Pagano JS
    Cancer Res; 2006 Oct; 66(20):9870-7. PubMed ID: 17047048
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SIAH proteins: critical roles in leukemogenesis.
    Krämer OH; Stauber RH; Bug G; Hartkamp J; Knauer SK
    Leukemia; 2013 Apr; 27(4):792-802. PubMed ID: 23038274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2.
    Nadeau RJ; Toher JL; Yang X; Kovalenko D; Friesel R
    J Cell Biochem; 2007 Jan; 100(1):151-60. PubMed ID: 16888801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on "the E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity." Qi J, Tripathi M, Mishra R, Sahgal N, Fazli L, Ettinger S, Placzek WJ, Claps G, Chung LW, Bowtell D, Gleave M, Bhowmick N, Ronai ZA, Signal Transduction Program, Cancer Center, Sanford-Burnham Medical Research Institute, La Jolla, CA, USA.: Cancer Cell 2013;23(6):332-46.
    Olumi AF
    Urol Oncol; 2014 Feb; 32(2):210-1. PubMed ID: 24445292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.